Spectrum Pharmaceuticals | SPPI - Interest Income


Spectrum Pharmaceuticals reported $117K in Interest Income for its fiscal quarter ending in June of 2022.



Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Agios Pharmaceuticals USD 13.37M 1.14M Sep/2025
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
Arrowhead Research USD 9.05M 1.97M Sep/2025
Astellas Pharma JPY 4.12B 2.94B Mar/2024
AstraZeneca USD 85M 17M Sep/2025
Bayer EUR 130M 38M Sep/2025
Biogen USD 31.6M 700K Sep/2025
Eli Lilly USD 65M 25M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Incyte USD 30.75M 3.97M Dec/2025
J&J USD 2.12 0.17 Sep/2025
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Merck USD 96M 27M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sanofi EUR 114M 38M Sep/2025
Takeda JPY 87.87B 43.48B Dec/2025